Washington Watch
— "It is endangering the lives of the oldest and sickest Americans," oncology group says
Latest in Washington Watch
Waiting for the results of the SRP-9001 confirmatory trial may be a better move
Upadacitinib lands indication for moderately to severely active disease in adults
Blumenthal: "It's fine, so long as you don't need it for the big stuff"
Suicide prevention in traumatic brain injury survivors also on the docket during hearing
Blumenthal: "It's fine, so long as you don't need it for the big stuff"
Suicide prevention in traumatic brain injury survivors also on the docket during hearing
More in Washington Watch
Agency reviewers signal little support for first potential nonalcoholic steatohepatitis drug
But Democrats argue it won't be enough to fix the healthcare system
Surgical oncologist is currently head of the National Cancer Institute
Whether vote means FDA will approve Sarepta's gene therapy remains to be seen
First-in-class drug works by blocking the NK3 receptor, which plays role in regulating body temp
Measure does not address scheduling the drug, which is frequently added to fentanyl
New language emphasizes potential for misuse, abuse, addiction, and overdose
Choice of alternative route with nasal spray outweighs possible risks, panelists say
Better prediction of shortages and more inspections of foreign plants are critical, experts say
New guidance ditches MSM-specific screening questions in effort to expand eligibility
This "is a moral issue," Sen. Bernie Sanders said during the hearing
Boxed warning on increased mortality risk in elderly patients remains for brexpiprazole
